118 related articles for article (PubMed ID: 3491643)
21. [Detection of hybrid DQ molecules by the use of T cell clone and 2D-gel analyses].
Hawkin S
Hokkaido Igaku Zasshi; 1986 Nov; 61(6):892-901. PubMed ID: 3493964
[TBL] [Abstract][Full Text] [Related]
22. Evidence for the expression of three different BoLA-class II molecules on the bovine BL-3 cell line: determination of a non-DR non-DQ gene product.
Ababou A; Goyeneche J; Davis WC; Lévy D
J Leukoc Biol; 1994 Aug; 56(2):182-6. PubMed ID: 7520928
[TBL] [Abstract][Full Text] [Related]
23. T cells specific for different antigens express different HLA-D region products.
Schendel DJ; Johnson JP
Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
[TBL] [Abstract][Full Text] [Related]
24. Protein analysis of HLA-DR2.3 haplotype.
Yabe T; Reinsmoen NL; Wu S; Bach FH
Hum Immunol; 1987 Jun; 19(2):127-37. PubMed ID: 3497139
[TBL] [Abstract][Full Text] [Related]
25. Molecular diversity of HLA-DQ. DQ alpha and beta chain isoelectric point differences and their relation to serologically defined HLA-DQ allospecificities.
Bontrop RE; Baas EJ; Otting N; Schreuder GM; Giphart MJ
Immunogenetics; 1987; 25(5):305-12. PubMed ID: 3570381
[TBL] [Abstract][Full Text] [Related]
26. Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues.
Temponi M; Kekish U; Hamby CV; Nielsen H; Marboe CC; Ferrone S
J Immunol Methods; 1993 May; 161(2):239-56. PubMed ID: 8505553
[TBL] [Abstract][Full Text] [Related]
27. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
[TBL] [Abstract][Full Text] [Related]
28. Two variants of DRw52, DR3, and DQw2 specificities distinguish two different DR3-bearing extended haplotypes.
Dasgupta JD; Relias V; Awdeh ZL; Alper CA; Yunis EJ
Hum Immunol; 1988 Feb; 21(2):133-42. PubMed ID: 2835344
[TBL] [Abstract][Full Text] [Related]
29. Identification with the monoclonal antibody 26.163 of a determinant shared by the beta chains of the gene products of the HLA-DR, DQ, and DP loci.
Igarashi M; Gebhard DH; Chen YX; Safai B; Evans RL; Ferrone S
Hum Immunol; 1986 Aug; 16(4):347-55. PubMed ID: 2428781
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.
Degener T; Momburg F; Möller P
Virchows Arch A Pathol Anat Histopathol; 1988; 412(4):315-22. PubMed ID: 3125670
[TBL] [Abstract][Full Text] [Related]
31. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
Diedrichs M; Schendel DJ
J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
[TBL] [Abstract][Full Text] [Related]
32. HLA-DR, DP and DQ expression in the small intestine of patients with coeliac disease.
Marley NJ; Macartney JC; Ciclitira PJ
Clin Exp Immunol; 1987 Nov; 70(2):386-93. PubMed ID: 3322617
[TBL] [Abstract][Full Text] [Related]
33. HLA-DR molecules on all cells are electrophoretically unique.
Pesando JM; Hoffman P; Stucki MA
Leuk Res; 1989; 13(9):851-62. PubMed ID: 2477648
[TBL] [Abstract][Full Text] [Related]
34. Correlation of HLA-D/Ii antigen expression in breast carcinoma with local lymphohistiocytic infiltration reveals considerable dysregulation in a subset of tumors.
Koretz K; Moldenhauer G; Majdic O; Möller P
Int J Cancer; 1989 Nov; 44(5):816-22. PubMed ID: 2583862
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization by high-resolution isoelectric focusing of the products encoded by the class II region loci of the major histocompatibility complex in humans. I. DR and DQ gene variants.
Rodriguez de Cordoba S; Nunez-Roldan A; Winchester R; Marshall P; Carrier C; Mollen N; Walker M; Ginsberg-Fellner F; Rubinstein P
Hum Immunol; 1987 Sep; 20(1):71-93. PubMed ID: 3679903
[TBL] [Abstract][Full Text] [Related]
36. A subset of HLA-DR9 molecules is detected by a polymorphic monoclonal antibody on lymphoblastoid cell lines but not on peripheral blood lymphocytes.
Cayrol C; Tkaczuk J; Sommer E; Cambon-Thomsen A
Hum Immunol; 1995 Sep; 44(1):19-27. PubMed ID: 8522451
[TBL] [Abstract][Full Text] [Related]
37. Expression of HLA-D sub-region products on human colorectal carcinoma.
Ghosh AK; Moore M; Street AJ; Howat JM; Schofield PF
Int J Cancer; 1986 Oct; 38(4):459-64. PubMed ID: 2428757
[TBL] [Abstract][Full Text] [Related]
38. A novel HLA class II molecule (DR alpha-DQ beta) created by mismatched isotype pairing.
Lotteau V; Teyton L; Burroughs D; Charron D
Nature; 1987 Sep 24-30; 329(6137):339-41. PubMed ID: 3306409
[TBL] [Abstract][Full Text] [Related]
39. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
Liu CP; Bach FH; Wu SK
J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
[TBL] [Abstract][Full Text] [Related]
40. Expression of HLA-DQ, -DR, and -DP antigens in normal kidney and glomerulonephritis.
Müller CA; Markovic-Lipkovski J; Risler T; Bohle A; Müller GA
Kidney Int; 1989 Jan; 35(1):116-24. PubMed ID: 2468811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
